China's BD111 Is the Most Advanced Gene-Editing Therapy for Herpes in Humans
Chinese biotech company BDgene Therapeutics, based in Shanghai, has developed BD111, a gene-editing therapy using CRISPR-Cas9 technology to target and remove...
Read More3 articles tagged with this topic
Chinese biotech company BDgene Therapeutics, based in Shanghai, has developed BD111, a gene-editing therapy using CRISPR-Cas9 technology to target and remove...
Read MoreHerpes simplex virus (HSV), which causes oral and genital herpes, remains a lifelong infection with no current cure. Traditional antiviral medications manage...
Read MoreEditorial note: This article was written in 2025 and covers HSV vaccine candidates as they stood at that time. Since then, Moderna has stopped mRNA-1608...
Read More